Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar 21;367(4):852-8.
doi: 10.1016/j.bbrc.2008.01.016. Epub 2008 Jan 14.

Mass spectrometric identification of lysine residues of heme oxygenase-1 that are involved in its interaction with NADPH-cytochrome P450 reductase

Affiliations

Mass spectrometric identification of lysine residues of heme oxygenase-1 that are involved in its interaction with NADPH-cytochrome P450 reductase

Yuichiro Higashimoto et al. Biochem Biophys Res Commun. .

Abstract

The lysine residues of rat heme oxygenase-1 (HO-1) were acetylated by acetic anhydride in the absence and presence of NADPH-cytochrome P450 reductase (CPR) or biliverdin reductase (BVR). Nine acetylated peptides were identified by MALDI-TOF mass spectrometry in the tryptic fragments obtained from HO-1 acetylated without the reductases (referred to as the fully acetylated HO-1). The presence of CPR prevented HO-1 from acetylation of lysine residues, Lys-149 and Lys-153, located in the F-helix. The heme degradation activity of the fully acetylated HO-1 in the NADPH/CPR-supported system was significantly reduced, whereas almost no inactivation was detected in HO-1 in the presence of CPR, which prevented acetylation of Lys-149 and Lys-153. On the other hand, the presence of BVR showed no protective effect on the acetylation of HO-1. The interaction of HO-1 with CPR or BVR is discussed based on the acetylation pattern and on molecular modeling.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Absorption spectral changes of the heme-rat HO-1 complex during the NADPH/CPR-supported single-turnover reaction
The spectra were recorded before (dotted line; ········) and after the addition of NADPH; 5 (dashed and dotted line; -·-·-), 10 (dashed line; ------) and 30 (solid line; —) min. (A) Unmodified HO-1, (B) HO-1 acetylated in the absence of CPR, (C) HO-1 acetylated in the presence of CPR. All reaction mixtures contained 5 μM heme-HO-1 complex, 40 nM CPR and 25 μM NADPH in 0.1M potassium phosphate buffer (pH 7.4).
Fig. 2
Fig. 2. Mass spectrometric analysis of the heme-rat HO-1 complex
(A) MALDI-TOF mass spectra of the tryptic peptides from rat HO-1: (a) unmodified, (b) acetylated in the absence of the reductases, (c) acetylated in the presence of CPR, (d) acetylated in the presence of BVR. The 16 solid arrows in (a) indicate the positions of the peptide fragment derived from the unmodified HO-1. The dashed arrows, 9 in (b) and (d) and 7 in (c) indicate the peaks of the acetylated peptides. The single solid-line arrows at m/z 1249 in (b), (c) and (d) indicate the Tyr-137-Lys-148 peptide without acetylation. In (c), the peak at m/z 1377 (asterisk) indicates the Tyr-137-Lys-149 peptide without acetylation and the 2 hollow arrows indicate the peaks, m/z 1419 and 1902, which were not detected in HO-1 acetylated in the presence of CPR. (B) Sequence and secondary structure of rat HO-1. Identified amino acid sequences in the mass spectra from heme-unmodified rat HO-1 complex are indicated by bold characters. The α-helices are shown as cylinders.
Fig. 3
Fig. 3. Putative docking model of rat HO-1 (PDB 1DVE) with rat BVR (1GCU) (A) and with CPR (1AMO) (B; ref 16) calculated by the program Hex
HO-1 is represented by a ribbon (purple). Heme is shown as ball-and-sticks (olive). The side chains of Lys-149 and Lys-153 in F helix of HO-1 are represented in stick form (red). BVR and CPR are shown as orange and green ribbons, respectively. The cofactors of CPR are in stick form (blue).

Similar articles

Cited by

References

    1. Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J. Biol. Chem. 1969;244:6388–6394. - PubMed
    1. Yoshida T, Noguchi M, Kikuchi G. Oxygenated form of heme. heme oxygenase complex and requirement for second electron to initiate heme degradation from the oxygenated complex. J. Biol. Chem. 1980;255:4418–4420. - PubMed
    1. Noguchi M, Yoshida T, Kikuchi G. Purification and properties of biliverdin reductases from pig spleen and rat liver. J Biochem. (Tokyo) 1979;86:833–848. - PubMed
    1. Strobel HW, Hodgson AV, Shen S. In: Cytochrome P450. Ortiz de Montellano, editor. Plenum Press; New York: 1995. pp. 225–244.
    1. Wang M, Robert DL, Paschke R, Shea TM, Masters BSS. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Proc. Natl. Acad. Sci. USA. 1997;94:8411–8416. - PMC - PubMed

Publication types

LinkOut - more resources